You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cHCC-CCA

Showing 1 - 25 of 65
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Precision Medicine for Combined

Recruiting
  • Liver Cancer
  • phenotyping
  • Créteil, France
    Julien Calderaro
Nov 17, 2023

Combined Hepatocellular Cholangiocarcinoma Trial (gemcitabine ,oxaliplatin,anlotinib,Sintilimab)

Not yet recruiting
  • Combined Hepatocellular Cholangiocarcinoma
  • gemcitabine ,oxaliplatin,anlotinib,Sintilimab
  • (no location specified)
Sep 10, 2023

Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma, Determine Efficacy of Liver Transplantation After Neoadjuvant

Not yet recruiting
  • Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma
  • Liver Transplant
  • Newark, New Jersey
  • +1 more
Nov 14, 2023

Intrahepatic Cholangiocarcinoma, Combined Hepatocellular and Cholangiocarcinoma Trial in Worldwide (derazantinib)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Combined Hepatocellular and Cholangiocarcinoma
  • Phoenix, Arizona
  • +40 more
Mar 7, 2022

Glioma Grading and Genotyping

Recruiting
  • Glioma
    • Chongqing, Chongqing, China
      Sang Zifan
    Aug 29, 2023

    Cholangiocarcinoma, Bile Duct Tumor, Biliary Tract Malignancy Trial run by the National Cancer Institute (NCI) (Tivozanib)

    Recruiting
    • Cholangiocarcinoma
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 6, 2022

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    Advanced Cholangiocarcinoma Trial in Hangzhou (Lenvatinib, tislelizumab, gemcitabine and cisplatin, Gemcitabine and cisplatin)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • Lenvatinib, tislelizumab, gemcitabine and cisplatin
    • Gemcitabine and cisplatin
    • Hangzhou, Zhejiang, China
      The Second Affiliated Hospital, Zhejiang University School of Me
    Apr 10, 2023

    Cholangiocarcinoma, Liver Cancer Trial in Houston (Infigratinib, Atezolizumab, Bevacizumab)

    Not yet recruiting
    • Cholangiocarcinoma
    • Liver Cancer
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    A Global Record of Anal Squamous Cell Carcinoma With and Without

    Not yet recruiting
    • Anal Squamous Cell Carcinoma
    • HIV Infections
      • (no location specified)
      Nov 28, 2022

      COVID-19 Trial in Yaoundé, Nairobi (Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics)

      Not yet recruiting
      • COVID-19
      • Integration of SARS-CoV 2 Testing in HIV, MNCH and TB Clinics
      • Yaoundé, Cameroon
      • +1 more
      Aug 16, 2022

      Detecting IgG4-related Sclerosing Cholangitis

      Completed
      • IgG4-related Sclerosing Cholangitis
      • IgG4-related Disease
        • Rochester, Minnesota
        • +1 more
        Jan 3, 2022

        Adenoid Hypertrophy Trial (Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage

        Not yet recruiting
        • Adenoid Hypertrophy
        • Adenoidectomy with endoscopic assisted coblation (EACA) and Adenoidectomy with conventional curettage (CCA)
        • (no location specified)
        Mar 20, 2022

        Common Bile Duct Tumors, Non-Neoplastic Bile Duct Disorder Trial in Worldwide (AI model classification, DSOC endoscopist

        Active, not recruiting
        • Common Bile Duct Neoplasms
        • Non-Neoplastic Bile Duct Disorder
        • AI model classification
        • DSOC endoscopist experts' classification
        • New Brunswick, New Jersey
        • +5 more
        Mar 30, 2022

        Cholangiocarcinoma Trial in Düsseldorf (Ivosidenib Oral Tablet)

        Recruiting
        • Cholangiocarcinoma
        • Ivosidenib Oral Tablet
        • Düsseldorf, Germany
          Klinik für Gastroenterologie, Hepatologie und Infektiologie Univ
        May 17, 2023

        Corpus Callosum Agenesis Trial in Paris (Decision-making process)

        Recruiting
        • Corpus Callosum Agenesis
        • Decision-making process
        • Paris, France
          Pitié-Salpêtrière Hospital, AP-HP - Department of Medical Geneti
        Apr 24, 2023

        Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors Trial in

        Active, not recruiting
        • Cholangiocarcinoma
        • +5 more
        • Gilbert, Arizona
        • +57 more
        Jan 5, 2022

        Cholangiocarcinoma Trial in Worldwide (Fimaporfin and Gemcitabine, Gemcitabine/Cisplatin chemo)

        Active, not recruiting
        • Cholangiocarcinoma
        • Fimaporfin and Gemcitabine
        • Gemcitabine/Cisplatin chemotherapy
        • Duarte, California
        • +49 more
        Mar 4, 2022

        POC-CCA Rapid Urine Test for Qualitative Detection of

        Completed
        • Aged ≥2 Years in Schistosomiasis Affected Areas
        • POC-CCA rapid urine test
        • Donggala, Central Of Sulawesi, Indonesia
          Donggala Research and Development (R&D) Center, Ministry of Heal
        Oct 31, 2021

        Cholangiocarcinoma, Gall Bladder Carcinoma, Cholangiocarcinoma Non-resectable Trial in Hannover (Durvalumab, Gemcitabine,

        Active, not recruiting
        • Cholangiocarcinoma
        • +3 more
        • Durvalumab
        • +3 more
        • Hannover, Germany
          Medizinische Hochschule Hannover, Klinik für Gastroenterologie,
        Oct 14, 2021

        Cholangiocarcinoma With IDH1 Mutation, Solid Tumors With IDH1 Mutation Trial in Beijing (AB-218 capsule)

        Not yet recruiting
        • Cholangiocarcinoma With IDH1 Mutation
        • Solid Tumors With IDH1 Mutation
        • AB-218 capsule
        • Beijing, Beijing, China
          Peking Union Medical College Hospital, Chinese Academy of Medica
        Apr 2, 2023

        The Effect of Trendelenburg Position on CCA Blood Flow

        Completed
        • Perfusion
        • Perioperative/Postoperative Complications
          • Seoul, Korea, Republic of
            Jin-Tae Kim
          Jan 17, 2022

          Cholangiocarcinoma, Cholangiocarcinoma Non-resectable, Cholangiocarcinoma, Perihilar Trial (ABC294640)

          Available
          • Cholangiocarcinoma
          • +4 more
          • (no location specified)
          Mar 14, 2022

          Circulating Cathodic Antigen Test Compared to Microscopy for

          Recruiting
          • Urinary Schistosomiases
            • Sohag, Egypt
              Faculty of medicine,Sohag University
            Apr 7, 2022

            Myocardial Bridge of Coronary Artery Trial in Izmir (radial access coronary angiography)

            Completed
            • Myocardial Bridge of Coronary Artery
            • radial access coronary angiography
            • İzmir, Turkey
              Cigli Training and Research Hospital
            May 4, 2021